CML-AP
Showing 851 - 858 of 858
Chronic Myeloid Leukemia Trial in Bologna (STI571 (400 mg/day; or 800 mg/day))
Completed
- Chronic Myeloid Leukemia
- STI571 (400 mg/day; or 800 mg/day)
-
Bologna, ItalyIstituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli"
Aug 9, 2007
Chronic Myeloid Leukemia Trial (STI571 and PEG INTRON)
Terminated
- Chronic Myeloid Leukemia
- STI571 and PEG INTRON
- (no location specified)
Aug 2, 2007
Chronic Myeloid Leukemia Trial in Lyon (Imatinib mesylate 600mg/day, Peg-Interféron at 90 microg/week)
Unknown status
- Chronic Myeloid Leukemia
- Imatinib mesylate 600mg/day
- Peg-Interféron at 90 microg/week
-
Lyon, FranceFranck NICOLINI
Apr 26, 2007
Chronic Myeloid Leukemia Trial in Innsbruck (Imatinib)
Unknown status
- Chronic Myeloid Leukemia
-
Innsbruck, Tyrol, AustriaMedical University Innsbruck
Jun 16, 2006
Chronic Myeloid Leukemia Trial in Poitiers (Imatinib mesylate 400 mg)
Completed
- Chronic Myeloid Leukemia
- Imatinib mesylate 400 mg
-
Poitiers, FranceUniversity Hospital
Dec 21, 2005
Leukemia,Myeloid, Chronic, Leukemia,Myeloid,Philadelphia-Positive Trial in Farmington (Heat Shock Protein 70 HSP70)
Completed
- Leukemia,Myeloid, Chronic
- Leukemia,Myeloid,Philadelphia-Positive
- Heat Shock Protein 70 HSP70
-
Farmington, ConnecticutUniversity of Connecticut Health Center
Jun 23, 2005
Significance of CXCR4-CXCL12 on Leukemic Cells Passing
Unknown status
- Acute Myelocytic Leukemia
- Acute Lymphocytic Leukemia
-
Taipei, TaiwanLiang-In Lin
Sep 9, 2005